Filing Details
- Accession Number:
- 0000711377-25-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-16 15:28:46
- Reporting Period:
- 2025-01-16
- Accepted Time:
- 2025-01-16 15:28:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1728876 | H. David Naemura | 620 Lesher Place Lansing MI 48912 | Cfo | No | Yes | No | No |
Transaction Summary
| Purchased: | 14,800 shares | Avg. Price: $11.11 | Total Value: $164,428.00 |
| Number of Shares After Transactions: | 61,434 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-16 | 14,800 | $11.11 | 61,434 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
